We are live on ! Find out more
HA

Hofer & Associates Portfolio holdings

AUM $207M
1-Year Est. Return 15.48%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+15.48%
3 Year Est. Return
+54.16%
5 Year Est. Return
10 Year Est. Return
AUM
$175M
AUM Growth
+$14.4M
Cap. Flow
+$5.85M
Cap. Flow %
3.35%
Top 10 Hldgs %
56.07%
Holding
61
New
6
Increased
31
Reduced
21
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 9.62%
2 Financials 5.17%
3 Healthcare 3.6%
4 Consumer Discretionary 2.31%
5 Consumer Staples 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
51
McDonald's
MCD
$194B
$260K 0.15%
857
+26
+3% +$7.91K
MA icon
52
Mastercard
MA
$497B
$254K 0.15%
446
-206
-32% -$118K
BILS icon
53
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.89B
$252K 0.14%
2,534
-405
-14% -$40.2K
PFXF icon
54
VanEck Preferred Securities ex Financials ETF
PFXF
$2.4B
$252K 0.14%
14,173
-902
-6% -$15.9K
BAC icon
55
Bank of America
BAC
$439B
$246K 0.14%
4,768
+320
+7% +$15.6K
TSLA icon
56
Tesla
TSLA
$1.21T
$235K 0.13%
+529
New +$183K
AXP icon
57
American Express
AXP
$227B
$230K 0.13%
694
-283
-29% -$90K
GCOW icon
58
Pacer Global Cash Cows Dividend ETF
GCOW
$3.4B
$229K 0.13%
5,783
-81
-1% -$3.18K
JNJ icon
59
Johnson & Johnson
JNJ
$643B
$221K 0.13%
1,190
-200
-14% -$34.3K
UNH icon
60
UnitedHealth
UNH
$389B
$214K 0.12%
+621
New +$188K
VTI icon
61
Vanguard Total Stock Market ETF
VTI
$656B
-670
Closed -$204K

Similar funds

Hofer & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Hofer & Associates held 61 positions worth $175M, up 9% from $160M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Hofer & Associates deployed $5.85M of net new capital in Q3 2025, opening 6 new positions and adding to 31 existing holdings. Its largest new stake was AbbVie: 3,135 shares worth $726K.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $460K trimmed.

  • Hofer & Associates's largest Q3 2025 buy was AbbVie: 3,135 shares worth $726K.
  • Hofer & Associates added most to Amgen in Q3 2025, an estimated $1.64M increase.
  • Hofer & Associates's biggest Q3 2025 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $460K.
  • Hofer & Associates fully exited Vanguard Total Stock Market ETF in Q3 2025, selling an estimated $204K.
  • Hofer & Associates's ten largest holdings make up 56% of its $175M portfolio in Q3 2025.
  • Hofer & Associates opened 6 new positions and closed 1 in Q3 2025.
  • Hofer & Associates's portfolio value rose 9% quarter-over-quarter to $175M.

Based on Hofer & Associates's 13F filing for Q3 2025, filed 21 Oct 2025.